Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1902)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$579.67
Total Value
$285.20K
Shares Held After
44,721
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$578.46
Total Value
$450.04K
Shares Held After
45,213
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,062
Price
$577.44
Total Value
$613.24K
Shares Held After
45,991
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
767
Price
$576.23
Total Value
$441.97K
Shares Held After
47,053
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
753
Price
$575.47
Total Value
$433.33K
Shares Held After
47,820
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$573.70
Total Value
$230.05K
Shares Held After
48,573
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
293
Price
$573.12
Total Value
$167.92K
Shares Held After
48,974
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$571.71
Total Value
$60.60K
Shares Held After
49,267
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$570.31
Total Value
$228.13K
Shares Held After
49,373
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$568.83
Total Value
$136.52K
Shares Held After
49,773
% of Holdings
0.5%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
475,000
Price
$1.34
Total Value
$636.50K
Shares Held After
10,453,988
% of Holdings
4.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,885
Price
$0.64
Total Value
$43.45K
Shares Held After
1,171,175
% of Holdings
5.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
75,000
Price
$100.12
Total Value
$7.51M
Shares Held After
523,478
% of Holdings
12.5%
Aclarion, Inc. (ACON)
Breidbart Scott — Director
Shares
5,664
Price
$3.18
Total Value
$18.01K
Shares Held After
5,664
% of Holdings
100.0%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$54.04
Total Value
$1.35M
Shares Held After
1,273,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
6,719
Price
$0.64
Total Value
$4.30K
Shares Held After
406,282
% of Holdings
1.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
94,432
Price
$0.64
Total Value
$60.44K
Shares Held After
5,709,858
% of Holdings
1.6%
Spok Holdings, Inc (SPOK)
KELLY VINCENT D — Director
Shares
5,000
Price
$10.70
Total Value
$53.48K
Shares Held After
167,565
% of Holdings
3.0%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
35,506
Price
$77.92
Total Value
$2.77M
Shares Held After
12,040
% of Holdings
74.7%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
845
Price
$78.40
Total Value
$66.25K
Shares Held After
47,546
% of Holdings
1.7%
Sensus Healthcare, Inc. (SRTS)
Sachetta Eric — Director
Shares
1,500
Price
$3.33
Total Value
$5.00K
Shares Held After
143,613
% of Holdings
1.0%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
6,476
Price
$5.76
Total Value
$37.30K
Shares Held After
188,448
% of Holdings
3.3%
Artiva Biotherapeutics, Inc. (ARTV)
GC Corp. — 10% Owner
Shares
347,222
Price
$11.52
Total Value
$4.00M
Shares Held After
1,607,734
% of Holdings
21.6%
Artiva Biotherapeutics, Inc. (ARTV)
GC Corp. — 10% Owner
Shares
1,085,069
Price
$11.52
Total Value
$12.50M
Shares Held After
4,391,969
% of Holdings
24.7%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
19,900
Price
$14.00
Total Value
$278.60K
Shares Held After
829,784
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$14.00
Total Value
$350.00K
Shares Held After
809,884
% of Holdings
3.1%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,100
Price
$14.00
Total Value
$71.39K
Shares Held After
784,884
% of Holdings
0.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$29.71
Total Value
$64.50K
Shares Held After
69,792
% of Holdings
3.0%
ANI PHARMACEUTICALS INC (ANIP)
Walsh Patrick D — Director
Shares
3,973
Price
$80.75
Total Value
$320.82K
Shares Held After
48,432
% of Holdings
7.6%
Janux Therapeutics, Inc. (JANX)
Dobek Maria — Vice President, Accounting
Shares
2,038
Price
$14.17
Total Value
$28.88K
Shares Held After
32,270
% of Holdings
5.9%
GLAUKOS Corp (GKOS)
Kliman Gilbert H — Director
Shares
5,000
Price
$135.00
Total Value
$675.00K
Shares Held After
35,528
% of Holdings
12.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: EVP, Chief Medical Officer
Shares
222
Price
$21.05
Total Value
$4.67K
Shares Held After
120,244
% of Holdings
0.2%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
105,439
Price
$22.55
Total Value
$2.38M
Shares Held After
450,004
% of Holdings
19.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
435
Price
$21.05
Total Value
$9.16K
Shares Held After
85,978
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
133,618
Price
$40.24
Total Value
$5.38M
Shares Held After
6,299,097
% of Holdings
2.1%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
22,562
Price
$29.12
Total Value
$657.01K
Shares Held After
519,397
% of Holdings
4.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,700
Price
$66.33
Total Value
$444.39K
Shares Held After
767,780
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,575
Price
$65.46
Total Value
$234.01K
Shares Held After
774,480
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,725
Price
$64.63
Total Value
$628.54K
Shares Held After
778,055
% of Holdings
1.2%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
3,385
Price
$22.60
Total Value
$76.50K
Shares Held After
211,462
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
22,177
Price
$6.75
Total Value
$149.69K
Shares Held After
176,713
% of Holdings
11.2%
Simulations Plus, Inc. (SLP)
Fiedler-Kelly Jill — President, Services Solutions
Shares
1,000
Price
$16.53
Total Value
$16.53K
Shares Held After
77,817
% of Holdings
1.3%
COLLEGIUM PHARMACEUTICAL, INC (COLL)
BOHLIN GAREN G — Director
Shares
8,700
Price
$37.18
Total Value
$323.49K
Shares Held After
62,259
% of Holdings
12.3%
Doximity, Inc. (DOCS)
Sitaram Siddharth — Interim PFO and PAO
Shares
2,309
Price
$25.77
Total Value
$59.50K
Shares Held After
89,396
% of Holdings
2.5%
DAVITA INC. (DVA)
Maughan David Paul — Chief Operating Officer, DKC
Shares
7,073
Price
$199.15
Total Value
$1.41M
Shares Held After
107,561
% of Holdings
6.2%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
7,500
Price
$32.64
Total Value
$244.80K
Shares Held After
18,802
% of Holdings
28.5%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
2,500
Price
$33.05
Total Value
$82.62K
Shares Held After
26,302
% of Holdings
8.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,510,416
Price
$11.52
Total Value
$75.00M
Shares Held After
15,203,995
% of Holdings
42.8%
Showing 651–700 of 1902 transactions (page 14 of 39)